Functional Regeneration in a Rat Parkinson's Model After Intrastriatal Grafts of Glial Cell Line-derived Neurotrophic Factor and Transforming Growth Factor Beta1-expressing Extra-adrenal Chromaffin Cells of the Zuckerkandl's Organ

Overview

Journal J Neurosci

Specialty Neurology

Date 2001 Dec 12

PMID 11739596

Citations 9

Authors

E F Espejo

J P Moraes

F El Banoua

J A Flores

I Caraballo

Affiliations

Soon will be listed here.

Abstract

Intrabrain transplantation of chromaffin cell aggregates of the Zuckerkandl's organ, an extra-adrenal paraganglion that has never been tested for antiparkinsonian treatment, induced gradual improvement of functional deficits in parkinsonian rats. These beneficial effects were related to long survival of grafted cells, striatal reinnervation, and enhancement of dopamine levels in grafted striatum. Grafted cells were not dopaminergics, but they expressed glial cell line-derived neurotrophic factor (GDNF) and transforming growth factor-beta(1). These factors were detected in the host striatal tissue, indicating that chromaffin cells secreted them after grafting. Because glial cell line-derived neurotrophic factor possesses neurorestorative properties over dopaminergic neurons, and transforming growth factor-beta(1) is a cofactor that potentiates the neurotrophic actions of GDNF, functional regeneration was likely caused by the chronic trophic action of neurotrophic factors delivered by long-surviving grafted cells. This work should stimulate research on the clinical applicability of transplants of the Zuckerkandl's organ in Parkinson's disease.

Citing Articles

Let's make microglia great again in neurodegenerative disorders.

Guillot-Sestier M, Town T J Neural Transm (Vienna). 2017; 125(5):751-770.

PMID: 29027011 PMC: 5897227. DOI: 10.1007/s00702-017-1792-x.

Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease.

Zhang Y, He X, Wu X, Lei M, Wei Z, Zhang X Cell Death Dis. 2017; 8(2):e2611.

PMID: 28182002 PMC: 5386462. DOI: 10.1038/cddis.2016.491.

Intrastriatal Grafting of Chromospheres: Survival and Functional Effects in the 6-OHDA Rat Model of Parkinson's Disease.

Boronat-Garcia A, Palomero-Rivero M, Guerra-Crespo M, Millan-Aldaco D, Drucker-Colin R PLoS One. 2016; 11(8):e0160854.

PMID: 27525967 PMC: 4985142. DOI: 10.1371/journal.pone.0160854.

Theoretical Approaches to Lentiviral Mediated Neurotrophin Delivery in Potential Treatments of Parkinson's Disease.

Qudrat A, Unni N Yale J Biol Med. 2016; 89(2):215-25.

PMID: 27354847 PMC: 4918865.

Transcription factor Six2 mediates the protection of GDNF on 6-OHDA lesioned dopaminergic neurons by regulating Smurf1 expression.

Gao J, Kang X, Sun S, Li L, Zhang B, Li Y Cell Death Dis. 2016; 7:e2217.

PMID: 27148690 PMC: 4917658. DOI: 10.1038/cddis.2016.120.

References

Hagg T . Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo. Exp Neurol. 1998; 149(1):183-92. DOI: 10.1006/exnr.1997.6684. View

Goetz C, Stebbins 3rd G, Klawans H, Koller W, Grossman R, Bakay R . United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical, and 1- and 2-year follow-up. Neurology. 1991; 41(11):1719-22. DOI: 10.1212/wnl.41.11.1719. View

Robinson T, Whishaw I . Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res. 1988; 450(1-2):209-24. DOI: 10.1016/0006-8993(88)91560-0. View

Paxinos G, Watson C, Emson P . AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J Neurosci Methods. 1980; 3(2):129-49. DOI: 10.1016/0165-0270(80)90021-7. View

Brundin P, Strecker R, Londos E, Bjorklund A . Dopamine neurons grafted unilaterally to the nucleus accumbens affect drug-induced circling and locomotion. Exp Brain Res. 1987; 69(1):183-94. DOI: 10.1007/BF00247041. View

Lyon R, Titeler M, Bigornia L, Schneider A . D2 dopamine receptors on bovine chromaffin cell membranes: identification and characterization by [3H]N-methylspiperone binding. J Neurochem. 1987; 48(2):631-5. DOI: 10.1111/j.1471-4159.1987.tb04139.x. View

Bjorklund A, Dunnett S, Stenevi U, Lewis M, Iversen S . Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res. 1980; 199(2):307-33. DOI: 10.1016/0006-8993(80)90692-7. View

Kirik D, Rosenblad C, Bjorklund A, Mandel R . Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J Neurosci. 2000; 20(12):4686-700. PMC: 6772474. View

Gundersen H, Jensen E . The efficiency of systematic sampling in stereology and its prediction. J Microsc. 1987; 147(Pt 3):229-63. DOI: 10.1111/j.1365-2818.1987.tb02837.x. View

10.

Unsicker K . The trophic cocktail made by adrenal chromaffin cells. Exp Neurol. 1993; 123(2):167-73. DOI: 10.1006/exnr.1993.1149. View

11.

Combs S, Krieglstein K, Unsicker K . Reduction of endogenous TGF-beta increases proliferation of developing adrenal chromaffin cells in vivo. J Neurosci Res. 2000; 59(3):379-83. DOI: 10.1002/(SICI)1097-4547(20000201)59:3<379::AID-JNR12>3.0.CO;2-5. View

12.

Unsicker K, Krieglstein K . Growth factor function in the development and maintenance of midbrain dopaminergic neurons: concepts, facts and prospects for TGF-beta. Ciba Found Symp. 1996; 196:70-80; discussion 80-4. DOI: 10.1002/9780470514863.ch6. View

13.

Sterio D . The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc. 1984; 134(Pt 2):127-36. DOI: 10.1111/j.1365-2818.1984.tb02501.x. View

14.

Yurek D, Sladek Jr J . Dopamine cell replacement: Parkinson's disease. Annu Rev Neurosci. 1990; 13:415-40. DOI: 10.1146/annurev.ne.13.030190.002215. View

15.

Wachtel S, Abercrombie E . L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors. J Neurochem. 1994; 63(1):108-17. DOI: 10.1046/j.1471-4159.1994.63010108.x. View

16.

Krieglstein K, Unsicker K . Bovine chromaffin cells release a transforming growth factor-beta-like molecule contained within chromaffin granules. J Neurochem. 1995; 65(3):1423-6. DOI: 10.1046/j.1471-4159.1995.65031423.x. View

17.

Ahonen M, Soinila S, Joh T . Pre- and postnatal development of rat retroperitoneal paraganglia. J Auton Nerv Syst. 1987; 18(2):111-20. DOI: 10.1016/0165-1838(87)90098-1. View

18.

Schober A, Hertel R, Arumae U, Farkas L, Jaszai J, Krieglstein K . Glial cell line-derived neurotrophic factor rescues target-deprived sympathetic spinal cord neurons but requires transforming growth factor-beta as cofactor in vivo. J Neurosci. 1999; 19(6):2008-15. PMC: 6782553. View

19.

Dunnett S, Bjorklund A . Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature. 1999; 399(6738 Suppl):A32-9. DOI: 10.1038/399a032. View

20.

Gash D, Zhang Z, Gerhardt G . Neuroprotective and neurorestorative properties of GDNF. Ann Neurol. 1998; 44(3 Suppl 1):S121-5. DOI: 10.1002/ana.410440718. View